Hubei Goto Biopharm Group Co., Ltd. (SZSE: 300966)
Health Care · Biotechnology · CN
CN¥25.17
-4.66% today · +7.9% 1Y
Hubei Goto Biopharm Group Co., Ltd. (SZSE: 300966) operates in the Biotechnology industry within the Health Care sector. The company is valued at $427.63M and employs 893 people.
Over the last twelve months the share price has gained 7.9%, trading between 18.44 and 32.58.
Tweenvest scores Hubei Goto Biopharm Group Co., Ltd. across four factors: quality 47/100, value 58/100, growth 0/100, dividend 3/100. Its strongest factor is value.
300966 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $427.63M
- Revenue (TTM)
- $91.18M
- P/E
- —
- EPS
- -0.62
- Dividend yield
- 0.18%
- Beta (5Y)
- 0.59
- 52-week high
- CN¥32.58
- 52-week low
- CN¥18.44
- Avg volume (3M)
- —
- Shares outstanding
- 114.21M
- Employees
- 893
- Next earnings
- —
About Hubei Goto Biopharm Group Co., Ltd.
Hubei Goto Biopharm Co.,Ltd. is a Chinese enterprise specializing in the manufacture and distribution of active pharmaceutical ingredients (APIs) and intermediate compounds for steroid hormones. Its product line features essential starting materials such as 9a-hydroxy-4-androstenedione (9a-OHAD), bisnoralcohol (BA), sitolactone, 1,4-androstadienedione (ADD), and 4-androstenedione (4-AD). The company also provides a variety of intermediates, including those for estrogens, progesterone, non-steroidal substances, various other hormones, and corticosteroids. Furthermore, Hubei Goto Biopharm supplies additional raw materials for the pharmaceutical industry. The firm was established in Yicheng, China, in 2006.
- ISIN
- CNE100004K94
- Founded
- 2006
- Listed since
- Apr 9, 2021
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.56 | +0.23% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.59 | +0.51% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.66 | +0.37% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $549.34 | +0.24% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $828.52 | -0.66% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $139.50 | -3.84% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.